Demonstrates targeted anticancer activity in cancer cells, suggesting novel treatment options.
Novel phenyl triazole-pyridylpiperazine derivatives were synthesized & tested against cancer cells. Compounds 15 & 18 showed potent anticancer activity comparable to doxorubicin, with favorable ADME profiles & stable EGFR binding.
No takes yet. Share an insight, caveat, or question.
Malah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: